NASDAQ:SNSS Shareholder News: Investigation over Potential Wrongdoing at Sunesis Pharmaceuticals, Inc.

San Diego, CA -- (SBWIRE) -- 05/16/2017 -- Certain directors of Sunesis Pharmaceuticals, Inc. are under investigation concerning possible wrongdoing. The investigation was announced for investors in NASDAQ:SNSS shares over potential breaches of fiduciary duties by certain directors at Sunesis Pharmaceuticals, Inc.